Glutamine supplementation in the critically ill: Friend or foe?

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Oudemans van Straaten, Heleen M ^a   van Zanten, Arthur R H ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; MUSCLE PROTEIN;

CRITICAL ILLNESS; CRITICALLY ILL PATIENT; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; INFLAMMATION; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; VENTILATED PATIENT; VITAMIN SUPPLEMENTATION; BLOOD; DIETARY SUPPLEMENT; FEMALE; MALE;

CRITICAL ILLNESS; DIETARY SUPPLEMENTS; FEMALE; GLUTAMINE; HUMANS; MALE;

EID: 84900816524     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13879     Document Type: Note

References (14)

1. Mori M, Rooyackers O, Smedberg M, Tjäder I, Norberg T, Wernerman J. Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation. Crit Care 2014, 18:R72. 10.1186/cc13829, 24731231.
2. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG., Canadian Critical Care Trials Group A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013, 368:1489-1497. 10.1056/NEJMoa1212722, 23594003, Canadian Critical Care Trials Group.
3. Newsholme EA, Crabtree B, Ardawi MS. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 1985, 70:473-489.
4. Calder PC. Glutamine and the immune system. Clin Nutrition 1994, 13:2-8.
5. Andawi MSM. Glutamine and glucose metabolism in human peripheral lymphocytes. Metabolism 1988, 37:99-103. 10.1016/0026-0495(88)90036-4, 3336288.
6. Tremel H, Kienle B, Weilemann LS, Stehle P, Fürst P. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994, 107:1595-1601.
7. Van der Hulst RR, Van Kreel BK, VonMeyenfeldt MF, Brummer RJM, Arends JW, Deutz NEP, Soeters PB. Glutamine and the preservation of gut integrity. Lancet 1993, 334:1363-1365.
8. Yue C, Tian W, Wang W, Huang Q, Zhao R, Zhao Y, Li Q, Li J. The impact of perioperative glutamine-supplemented parenteral nutrition on outcomes of patients undergoing abdominal surgery: a meta-analysis of randomized clinical trials. Am Surg 2013, 79:506-513.
9. Lin JJ, Chung XJ, Yang CY, Lau HL. A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn. Burns 2013, 39:565-570. 10.1016/j.burns.2012.11.008, 23313017.
10. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, Morrow FD, Jacobs DO, Smith RJ, Antin JH, Wilmore DW. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992, 116:821-828. 10.7326/0003-4819-116-10-821, 1567096.
11. Griffiths RD, Jones C, Palmer TEA. Six month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997, 4:296-302.
12. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008, 34:1980-1990. 10.1007/s00134-008-1213-6, 18626628.
13. Kao C, Hsu J, Bandi V, Jahoor F. Alterations in glutamine metabolism and its conversion to citrulline in sepsis. Am J Physiol Endocrinol Metab 2013, 304:E1359-E1364. 10.1152/ajpendo.00628.2012, 23612995.
14. Souba WW, Herskowitz K, Klimberg VS, Salloum RM, Plumley DA, Flynn TC, Copeland EM. The effects of sepsis and endotoxemia on gut glutamine metabolism. Ann Surg 1990, 211:543-549. 10.1097/00000658-199005000-00004, 1358220, 2339916.